With histamine used as agonist, pKB values were estimated for seventeen histamine H2-receptor antagonists on assays involving acid secretion by the mouse isolated stomach and contraction frequency of the guinea-pig right atrium. 2 With the exception of oxmetidine, SK&F 94,826 and SK&F 94,206 on the right atrium assay, the compounds behaved as simple competitive antagonists on both assays. Although the former three compounds produced concentration-dependent, parallel, displacement of the histamine concentration-effect curves, subsequent analysis indicated Schild plot slope parameters significantly less than unity. However, the application of a combined dose-ratio analysis indicated that their antagonistic behaviour did not differ from expectations for simple competition at dose-ratios of approximately 20, and pKB values were estimated on this basis.
Introduction
In a previous paper (Black et al., 1985) we extended the original studies of Angus & Black (1979) and who found that the calculated pK, values obtained for the histamine H2-receptor antagonists, burimamide, metiamide and cimetidine were significantly lower in the isolated, lumenperfused, stomach preparation of the mouse than in the guinea-pig right atrium-assay. Although confirming the original results, our examination of a further three antagonists, ranitidine, oxmetidine and famotidine, indicated that the differences between the pKB values obtained on the gastric and atrial assays were not constant. Subsequently, we observed a similar phenomenon when pK, values were estimated for 1 Author for correspondence. three muscarinic receptor antagonists both on the mouse stomach and guinea-pig trachea assays (Black & Shankley, 1985a) . The pKB value for atropine was found to be underestimated to a greater extent on the gastric acid assay than the pKB values obtained for pirenzepine and N-methylatropine. We suggested that lipophilicity was a determinant of the degree of pKB underestimation in the gastric acid assay because atropine exhibits greater lipophilicity than pirenzepine and N-methylatropine. In accord with the original hypothesis of Angus & Black (1979) and , the compounds were imagined to partition across the gastric mucosa resulting in a net, lower, concentration of antagonist in the region of the oxyntic cell receptors. The above hypothesis requires that the underestimation of antagonist affin-©D The Macmillan Press Ltd 1988 ity in the mouse stomach assay is independent of the class of receptor under investigation. The underestimation should be a simple function of extent of partitioning across the mucosa. The ability of a compound to penetrate biological membranes has been correlated with its oil/water partition coefficients (Hansch & Leo, 1979) . Accordingly, in this study, we have examined a series of histamine H2-receptor antagonists which were selected to allow investigation of the relationship between antagonist lipophilicity, expressed as log POCT/H2O0 and the underestimation of pKB value in the mouse stomach assay. In addition, the effect of removing the serosal muscle on pKB value underestimation was investigated on an isolated, perfused, mucosal sheet preparation of the mouse.
Methods

Acid secretion
Gastric acid secretion was measured in the isolated, lumen-perfused, stomach preparation of the mouse as described previously (Black & Shankley, 1985b) . Briefly, stomach preparations were established with the pH-electrode system arranged to provide a 12 cmH20 pressure to distend the stomach. Six preparations were used simultaneously and after an initial 60 min stabilization period those not producing a stable basal acid secretion (approximately 5%) were rejected. All drugs were added directly to the organ bath (serosal side) and, following a further 60 min equilibration period in the absence or presence of antagonist, a single cumulative agonist concentration-effect curve was obtained.
In a separate series of experiments, gastric acid secretion was studied in an isolated, perfused, mucosal sheet preparation of the mouse. The technique used the same principles applied by Main & Pearce (1978) to the development of the rat mucosal sheet preparation. In brief, the stomach, from the same stock of mice used for the whole stomach assay, was opened by incision along the greater curvature. The glandular part of the stomach was gently stretched and ligated over a perspex disc (10 mm ext. dia.) to produce a water-tight seal. Approximately 0.5 ml of mucosal solution was injected, through a fine needle, between the mucosa and serosal muscle layers and the blister of muscle produced was carefully removed with fine iridectomy scissors. The mucosal surface of the sheet was perfused at 0.5 ml minm ' with mucosal solution via two stainless steel tubes (2mm int. diam.) passing through the centre of the perspex disc. The whole preparation was then lowered into a 40 ml organ bath containing serosal solution (Black & Shankley, 1985b) . In other respects the assay was identical to that employed for the whole stomach with the exception that the pHelectrode system was arranged to provide only a 5 cmH20 pressure which slightly distended the mucosal sheet.
Guinea-pig right atrium preparation Chronotropic effects were studied in isolated, spontaneously-beating, right atria from male guineapigs (for details see . Briefly, tissues were subjected to 0.5 g resting tension and washed at approximately 15min intervals during an initial 60 min stabilization period. Krebs-Henseleit solution was routinely prepared containing propranolol 10-7M to inhibit the effects of histaminestimulated catecholamine release. Six preparations were used simultaneously and following the initial stabilization period and a 60min equilibration period in the absence or presence of antagonist, a single cumulative agonist concentration-effect curve was obtained.
Experimental design
Experimental treatments were allocated on a block design such that, as far as possible, all organ baths received each treatment during the course of an experiment.
Analysis
Individual responses to drug treatments were measured as changes from basal response levels immediately prior to drug addition. Acid secretion responses were measured as the change in pH of the lumen perfusate (ApH) and guinea-pig right atrium responses as changes in rate (A beats min ). The concentration-effect curve data from individual preparations were fitted to a logistic function which provided estimates of the mid-point location parameter (log[A50]), maximal asymptote (a) and mid-point slope (n), as described previously (Black & Shankley, 1985b) . Analyses of agonist-antagonist interactions and subsequent estimation of antagonist dissociation constant (pKB) values were performed as described previously (Black et al., 1985) .
Combined dose-ratio analysis
A combined concentration-ratio analysis, based on the technique of Paton & Rang (1965) The standard error of SM is given by (7) log P determination Octanol: water partition coefficients for the free base of the histamine H2-receptor antagonists were determined at 370C by a shake-flask technique using an aqueous buffer at pH 9.0 unless otherwise indicated in Table 1 . The phases were allowed to settle out under gravity. The concentrations of compound in the aqueous phase before and after partitioning were determined spectrophotometrically, and buffer salts were used to control the pH of the aqueous phase.
Log P for the free base form was derived from the equation, log P = log Pa + log(1 + 0PKa-pH)
where log P. is the apparent partition measured at the given pH.
Drugs
Drugs were prepared in distilled water. Molar stock solutions of histamine dihydrochloride (Sigma) were neutralised by addition of sodium hydroxide (Black et al., 1981) . The total volume of drug added in any one experiment to the 20ml (atria) and 40 ml (Paton & Rang, 1965) ,
Writing equation (5) (6) where SM is the test-statistic for the multiplicative model. Thus, if the antagonists behave in accord with the multiplicative model SM (equation (6)) should have a value of zero.
Results
Estimation ofpKB valuesfor histamine H2-receptor antagonists on the whole stomach and guinea-pig atrium assays Black et al., 1985) with the slope parameter, b, constrained to unity. The pKB estimates obtained are shown in Table 1 .
Comparison ofpKB values obtainedfrom atrium and stomach As we found previously (Black et al., 1985a) the pKB values obtained on the stomach assay were consistently lower than those found on the guinea-pig right atrium. A significant correlation (r = 0.80: P < 0.01) was found between the difference in pKB values (ApKB) and the lipophilicity of the compounds, the latter expressed in terms of their octanol/water partition coefficients (log PocIH2o). Examination of the log PocT/H2o/ApKB plot (Figure 1) 23 pKa values for picolyl ring (5.9) and isocytosine ring (9.78, dissociation to anion) respectively. The methoxypyridyl ring has PKa 5.5 (Ganellin et al., 1986) . 24 pKa by analogy with impromidine . 25 (Table 2) . Kenakin (1984) , among others, has illustrated how underlying complexity in several experimental situations can in the first instance go undetected due to the apparently simple competitive behaviour of an agonist-antagonist interaction. Complexities such as, for example, agonist uptake processes and two receptor systems are usually revealed by using more than one antagonist and/or agonist. Accordingly, confidence in the conclusion of competitivity in the action of an antagonist, and therefore the validity of the pKB estimate, increases proportionally with the number of agonist-antagonist interactions investigated which produce simple competitive behaviour. For example, the low Schild plot slope parameters estimated from the analysis of the interaction between histamine and the three compounds, SK&F 94,206, SK&F 94,826 and oxmetidine, on the guineapig right atrium assay (Table 1) could be indicative of complexities such as those mentioned above. However, the results of the combined dose-ratio analysis, the apparent simple behaviour of these three compounds on the stomach assay and the simple behaviour of the remainder of the compounds on both assays, when considered together, suggest that histamine does interact with a single receptor population in each assay.
In the present study the criteria for simple competition were satisfied with a whole range of histamine H2-receptor antagonists, using histamine as agonist (Table 1 ). In addition the criteria were also satisfied and similar pKB values estimated when the selective histamine H2-receptor agents, dimaprit (Angus & Black, 1979) and impromidine (Table 1) were used as agonists. Thus, if no further information was available the low values of pKB obtained on the mouse stomach assay could be considered as preliminary evidence for histamine H2-receptor heterogeneity.
However, in the previous analyses of the underestimation of pKB values on the mouse stomach assay (Angus & Black, 1979; Black et al., 1985; Black & Shankley, 1985a, c) , a more conservative explanation for the results was preferred because similar underestimation of pKB values was found for muscarinic receptor antagonists on the mouse stomach assay, which was also independent of the agonist used. The antagonists were imagined to partition across the gastric mucosa, resulting in a net lower concentration of antagonist in the region of the oxyntic cell receptors in the mouse stomach assay. Such a process would occur independently of the receptor class involved, as found experimentally. In addition, the difference in antagonist behaviour on the stomach assay compared to the behaviour on the guinea-pig right atrium and trachea assays for histamine H2-and muscarinic receptor antagonists, respectively, was seen only as a parallel displacement of the Schild plot; that is, no evidence was obtained to indicate that the loss process approached saturating conditions. Furthermore, steady-state agonist responses were obtained which is consistent with the view that steady-state concentrations of the agonist and antagonist were achieved in the region of the hormone receptors. The simplest model to account for all these data involves, firstly, the diffusion of the antagonist from the serosal bathing solution into the receptor compartment and, secondly, the subsequent loss of the antagonist through the mucosal membrane into the gastric acid secretion. The positive, significant correlation found between the lipophilicity of the compounds and the degree of pKB underestimation on the mouse stomach assay for both muscarinic and histamine H2-receptor antagonists (Figure 1 ) supports the general hypothesis that the hormone receptors in the mouse stomach are homogeneous with those found on the guinea-pig right atrium and trachea assays. However, the finding that a single lipophilicity parameter correlates with the antagonist behaviour is perhaps rather surprising. The model involves two processes, diffusion and passage through the mucosal membrane, and we might expect that it is only the rate of the latter process that is related to lipophilicity. The correlation may well be improved if an additional parameter relating to the diffusion process were included. Similarly, the choice of octanol/H20 coefficients as a measure of lipophilicity was arbitrary, the data were more readily available, and the use of partitioning data using different solvent pairs might also improve the correlation. Interestingly, the results obtained on the isolated, perfused, mucosal sheet preparation indicate that the removal of the serosal muscle layer does not facilitate antagonist concentration equilibrium between the serosal solution and receptor compartment.
The histamine H2-antagonists originally studied (Black et al., 1985) (compounds 1-7 in Table 1 and Figure 1 ) are relatively weak bases having pKa values (6.5-8) near physiological neutrality, thus permitting a substantial proportion of compound molecules to be in the uncharged (i.e. non-protonated) form which is most readily able to cross lipoidal cell membranes. In an attempt to test whether local pH effects could complicate the relationship between lipophilicity and pKB underestimation, a pair of compounds (SK&F 92, 363 and SK&F 92, 629 , compounds 10 and 11 in Table 1 and Figure 1 ), were assayed. These compounds have a very low pK, (1.8) and presumably remain mainly unprotonated even over the pH range likely to be encountered in the mouse stomach assay. The compounds are thiazole analogues of the more basic imidazole compounds, cimetidine (compound 3) and SK&F 92,456 (compound 16) respectively. The pKB values obtained were similar, indicating that the extent of protonation, for these compounds at least, does not contribute significantly to the process responsible for pKB underestimation on the mouse stomach assay. By contrast, SK&F 92,540 (compound 15) was selected as a guanidine derivative (pKa > 11) which will be almost exclusively protonated (>99.9%) at pH 7.4 and, therefore, should theoretically possess low ability to penetrate membranes. The fact that the pKB value was significantly underestimated (Table 1) suggests that the compound is in fact able to penetrate membranes, presumably due to rapid equilibration between the protonated and neutral conjugate base form.
An interesting pair of compounds are the methoxypyridine derivatives, SK&F 92,857 (compound 12) and SK&F 93,162 (compound 13), which differ solely in the side-chain atoms where -CH2-replaces -S-. These compounds, when initially synthesized and tested in vivo in the rat were found to differ considerably as inhibitors of histaminestimulated gastric acid secretion (M.E. Parsons, personal communication: as tested by i.v. administration against a near maximal stimulation of acid secretion produced by histamine infusion in a modified Ghosh-Schild preparation of the lumen-perfused stomach of the anaesthetized rat). SK&F 93,162 was found to be some 30 fold weaker in activity, although their respective affinities for the histamine H2-receptor estimated in the guinea-pig right atrium assay in this study only differ by 4.5 fold (Table 1) . At the time of initial testing, the reason for the difference was not understood and, in the absence of specific information, was attributed to in vivo effects such as a presumed rapid metabolic deactivation of SK&F 93,162. Apparently, there is no need to invoke such effects in vivo because the difference in potency is also expressed on the isolated mouse stomach assay. SK&F 93, 319 (compound 14) and SK&F 93, 479 (compound 8) are isocytosine derivatives and were tested for comparison with oxmetidine (compound 7, also an isocytosine). They differ from oxmetidine, however, in possessing a methyl picolyl group as a 5-substituent in the isocytosine ring instead of a methylene-dioxybenzyl group, but the lipophilicities of these two groups are similar. The results obtained from the assay of these two compounds were found to lie on the best-fit regression between log POCT/H20 and ApKB. At this time, we cannot explain why the data obtained with oxmetidine do not fit the regression. SK&F 94, 206 (compound 17) and SK&F 94,826 (compound 9) were selected simply as examples of compounds previously found to be weak inhibitors of histamine-stimulated acid secretion in vivo in the rat (M.E. Parsons, personal communication). They were also found to have very low activity on the mouse stomach assay, although both were potent antagonists in the guinea-pig right atrium assay (Table 1) .
In a previous report (Black & Shankley, 1985a) we suggested that the ability of pirenzepine to display selective inhibition of acid secretion, in vivo, compared to atropine could simply be due to lack of loss into the gastric acid secretion and hence an effective blocking concentration would occur at much lower plasma levels. The above findings in the rat, using SK&F 94, 826 and SK&F 94, 206 , indicate that the same process could occur for histamine H2-receptor antagonists and adds support to the notion that the pKB underestimation observed in vitro is relevant to the in vivo situation.
In conclusion, it would appear that the inconsistencies among antagonist pKB values for the muscarinic and histamine H2-receptors antagonists can be accounted for without the need to postulate heterogeneity of receptor populations. Although log P values measured between octanol and water may perhaps not be expected to be the best indicators of the behaviour of the antagonists in the system, the correlation observed between log POCTIH2o and ApKB values does suggest that the degree of underestimation of antagonist affinity is related to the lipophilicity of the antagonists.
